Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Radius Health (RDUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 885,950
  • Shares Outstanding, K 45,480
  • Annual Sales, $ 22,110 K
  • Annual Income, $ -254,240 K
  • 36-Month Beta 0.94
  • Price/Sales 40.06
  • Price/Cash Flow N/A
  • Price/Book 6.48

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -1.27
  • Number of Estimates 5
  • High Estimate -1.19
  • Low Estimate -1.42
  • Prior Year -1.31
  • Growth Rate Est. (year over year) +3.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.94 +11.92%
on 09/25/18
20.36 -6.88%
on 10/16/18
+0.52 (+2.82%)
since 09/19/18
3-Month
16.71 +13.46%
on 09/18/18
28.84 -34.26%
on 07/24/18
-9.50 (-33.38%)
since 07/19/18
52-Week
16.71 +13.46%
on 09/18/18
41.16 -53.94%
on 01/29/18
-17.02 (-47.30%)
since 10/19/17

Most Recent Stories

More News
Radius Health In Set to Possibly Pullback After Yesterday's Rally of 1.20%

Radius Health In (NASDAQ:RDUS) traded in a range yesterday that spanned from a low of $18.80 to a high of $19.55. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high...

RDUS : 18.96 (-2.67%)
Radius Health to Announce Third Quarter 2018 Financial Results, Host Conference Call and Live Webcast on November 1, 2018

Radius Health (Nasdaq: RDUS) announced today that it will release its third quarter financial results on Thursday, November 1, 2018. The Company will host a conference call and live audio webcast at 8:00...

RDUS : 18.96 (-2.67%)
Radius Health In Down 34.5% Since SmarTrend Downtrend Call (RDUS)

SmarTrend identified a Downtrend for Radius Health In (NASDAQ:RDUS) on June 27th, 2018 at $28.29. In approximately 4 months, Radius Health In has returned 34.49% as of today's recent price of $18.53.

RDUS : 18.96 (-2.67%)
Report: Exploring Fundamental Drivers Behind Skyworks Solutions, Radius Health, Novanta, Flowers Foods, Rexford Industrial Realty, and Donaldson -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Skyworks Solutions, Inc....

RDUS : 18.96 (-2.67%)
FLO : 19.06 (+1.82%)
SWKS : 85.16 (-1.24%)
NOVT : 65.99 (-0.39%)
REXR : 31.26 (+0.26%)
DCI : 52.41 (-0.64%)
Insmed Inc has the Best Relative Performance in the Biotechnology Industry (INSM , RDUS , FOLD , ALDR , AMAG )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

FOLD : 11.97 (-2.60%)
RDUS : 18.96 (-2.67%)
INSM : 16.41 (-3.64%)
Radius Health Announces Latest 2019 Medicare Part D Coverage for TYMLOS(R) (abaloparatide) Injection

WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative...

ESRX : 95.30 (-0.88%)
RDUS : 18.96 (-2.67%)
WCG : 308.74 (-2.65%)
Radius Health to Present at the Leerink Partners Oncology Roundtable Series

Radius Health, Inc. (Nasdaq: RDUS) announced today that Jesper Høiland, President and CEO and Charles Morris, Chief Medical Officer of the Company will present a corporate update at the Leerink Partners...

RDUS : 18.96 (-2.67%)
Downtrend Call Working As Radius Health In Stock Falls 38.3% (RDUS)

SmarTrend identified a Downtrend for Radius Health In (NASDAQ:RDUS) on June 27th, 2018 at $28.29. In approximately 3 months, Radius Health In has returned 38.31% as of today's recent price of $17.45.

RDUS : 18.96 (-2.67%)
Radius Health to Present Data on Abaloparatide at ASBMR 2018 Annual Meeting

Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis...

RDUS : 18.96 (-2.67%)
Downtrend Call Working As Radius Health In Stock Falls 35.5% (RDUS)

SmarTrend identified a Downtrend for Radius Health In (NASDAQ:RDUS) on June 27th, 2018 at $28.29. In approximately 3 months, Radius Health In has returned 35.48% as of today's recent price of $18.25.

RDUS : 18.96 (-2.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade RDUS with:

Business Summary

Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both...

See More

Key Turning Points

2nd Resistance Point 20.31
1st Resistance Point 19.63
Last Price 18.96
1st Support Level 18.54
2nd Support Level 18.13

See More

52-Week High 41.16
Fibonacci 61.8% 31.82
Fibonacci 50% 28.93
Fibonacci 38.2% 26.05
Last Price 18.96
52-Week Low 16.71

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar